| Characteristic | Revenue in million euros |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Region
Worldwide
Survey time period
2007
Supplementary notes
* Including Barr and Pliva.
** Including Hexal.
*** Including Merck Generics.
**** Including Betapharm.
Citation formats









